Can a simple device accurately track muscle paralysis in the ICU?
NCT ID NCT07741851
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study evaluates how reliably a device monitors neuromuscular blockade (temporary muscle paralysis) in adult intensive care patients. The goal is to see if the device's readings match the expected response in patients without paralysis, and whether using it helps avoid complications like breathing difficulties. Researchers will compare different stimulation methods and track safety over 24-hour periods. The findings could improve how ICU teams monitor and manage muscle relaxants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- neuromuscular blockade monitoring using the TOFscan Idmed device
- What this could lead to
- If reliable, this monitoring method could help ICU teams better manage muscle paralysis, reducing risks and improving patient safety.
- What could go wrong
- The study is observational and may not capture all clinical variations. Device readings might not always match real conditions, and results may not apply to all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 160 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients * Patients admitted to the intensive care unit who have been receiving neuromuscular blocking agents for at least 24 hours during their stay - Consent obtained from the patient or emergency consent obtained from family members * Patients covered by the French social security system, regardless of the specific plan Exclusion Criteria: * Patients who have already been exposed to prolonged neuromuscular blockade or who have been receiving continuous neuromuscular blockade for less than 24 hours * Allergy to neuromuscular blocking agents * Patients with a neurological condition that alters the interpretation of neuromuscular blockade or contraindicates the use of neuromuscular blocking agents * Patients enrolled in an interventional study * Patients who object to the collection of their medical data for this study * Patients under the age of 18 * Patients deprived of their liberty, under guardianship, or under conservatorship * Pregnant or breastfeeding women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neuromuscular blockade monitoring are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre Hospitalier Intercommunal Aix-Pertuis
RECRUITINGAix-en-Provence, 13090, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.